947 The activation states of tumor-resident type 2 dendritic cells impact the strength of ovarian cancer immune responses by Stefani Spranger, Fiona Chatterjee, Emi A Lutz, K Dane Wittrup, Vincent Butty

1011 The signal strength of signal 2 and 3 during T cell priming affect the functional fate of an anti-tumor T cell response by Stefani Spranger, Duncan Morgan, Vidit Bhandarkar, Teresa Dinter, Lorelai Pop, Emi A Lutz, K Dane Wittrup, J Christopher Love

An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy by Sarah C. Cowles, Allison Sheen, Luciano Santollani, Emi A. Lutz, Brianna M. Lax, Joseph R. Palmeri, Gordon J. Freeman, K. Dane Wittrup

Get full text

1224 Tregs constrain CD8 + T cell priming required for curative intratumorally anchored anti-4–1BB immunotherapy by Emi A Lutz, K Dane Wittrup, Joseph R Palmeri, Brianna M Lax, Josh M Peters, Lauren Duhamel, Jordan A Stinson, Luciano Santollani, William Pinney, Bryan D Bryson

CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs by Joseph R. Palmeri, Brianna M. Lax, Joshua M. Peters, Lauren Duhamel, Jordan A. Stinson, Luciano Santollani, Emi A. Lutz, William Pinney, Bryan D. Bryson, K. Dane Wittrup

Get full text

Enhanced Vaccine Immunogenicity Enabled by Targeted Cytosolic Delivery of Tumor Antigens into Dendritic Cells by Nicholas L. Truex, Aurélie Rondon, Simon L. Rössler, Cameron C. Hanna, Yehlin Cho, Bin-You Wang, Coralie M. Backlund, Emi A. Lutz, Darrell J. Irvine, Bradley L. Pentelute

Get full text